The global spinal cord stimulators market will likely reach $3.57 billion by 2027, according to a Future Market Insights report.
Here are nine observations:
1. In 2017, the market is valued at $2 billion.
2. The market is expected to grow at a compound annual growth rate of 6.4 percent through 2027.
3. Rechargeable SCS are anticipated to continue dominating the market, with sales reaching $2.53 billion by 2027.
4. Non-rechargeable SCS will likely grow at a 4.6 percent CAGR.
5. The SCS application for failed back surgery syndrome will remain dominant throughout the forecast period. Sales will likely exceed $1 billion in 2017.
6. The complex regional pain syndrome comes in second for SCS application, with sales expected to grow at a 5.8 percent CAGR through 2027.
7. North America will lead the global market, with sales hitting $3 billion by 2027.
8. Western Europe comes in second, growing at a 6.1 percent CAGR through 2027. Eastern Europe and Japan will both grow at a 6 percent CAGR through 2027.
9. Boston Scientific, Medtronic, St Jude Medical, Nevro, Nuvectra, Stimwave and Saluda Medical lead the market.